Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2005-10-11
2005-10-11
Saunders, David (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S085100, C424S810000, C514S002600, C514S866000, C514S885000
Reexamination Certificate
active
06953578
ABSTRACT:
The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
REFERENCES:
patent: 4409243 (1983-10-01), Lieb
patent: 4490385 (1984-12-01), Lieb
patent: 5008240 (1991-04-01), Bentz et al.
patent: 5449515 (1995-09-01), Hamilton et al.
patent: 5449688 (1995-09-01), Wahl et al.
patent: 5466823 (1995-11-01), Talley et al.
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5476659 (1995-12-01), Goodman et al.
patent: 5512447 (1996-04-01), Baekkeskov et al.
patent: 5538854 (1996-07-01), Faustman
patent: 5601815 (1997-02-01), Powrie et al.
patent: 5604260 (1997-02-01), Guay et al.
patent: 5643786 (1997-07-01), Cohen et al.
patent: 5681842 (1997-10-01), Dellaria et al.
patent: 5827513 (1998-10-01), Bond et al.
patent: 6048850 (2000-04-01), Young et al.
patent: 6168792 (2001-01-01), Clare-Salzler
patent: 6403562 (2002-06-01), Johnson et al.
patent: 0436333 (1991-07-01), None
patent: 9220811 (1992-11-01), None
patent: 9408606 (1994-04-01), None
patent: 9518799 (1995-07-01), None
patent: 9523599 (1995-09-01), None
patent: 95/27500 (1995-10-01), None
patent: 9621654 (1996-07-01), None
The Merck Index, Thirteenth Edition, pp. 336, 1481.
Science, 294, 1638-1639, 2003.
Ibelgaufts, Dictionary of Cytokines, pp. 393-398, 416-419, 423-425, 685-693, Pub. 1995.
Coffey, R.G., V.A. Alberts, L.L. Weakland (1990) “Prostaglandin-Dependent Desensitization of Human Monocyte cAMP Responses”J. Leukocyte Biol.48:557-564.
Crofford et al. (1994) “Cyclooxygenase-1 and -2 Expression in Rheumatoid Synovial Tissues”J. Clin. Invest.93:1095-1101.
Endres, S. et al., (1991) “Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-α and interleukin-1β by human mononuclear cells”Immunology72:56-60.
Farber, Joshua M. (1992) “A Collection of mRNA Species That Are Inducible In The RAW 264.7 Mouse Macrophage Cell Line by Gamma Interferon and Other Agents”Molecular and Cellular Biology12(4):1535-1545.
Hafler, David A., Marion Buchsbaum, Howard L. Weiner (1985) “Decreased Autoogous Mixed Lymphocyte Reaction In Multiple Sclerosis”Journal of Neuromimmunology9:339-347.
Howard, M. et al. (1992) “Biological Propeties of Interleukin 10”Journal of Clinical Immunology12(4):239-247.
Kujubu, D.A. et al. (1991) “TIS10, a Phorbol Ester Tumor Promoter-inducible mRNA from Swiss 3T3 Cells, Encodes a Novel Prostaglandin Synthase/Cyclooxygenase Homologue”Journal of Biological Chemistry266(20):12866-12872.
Mertz, Prema M., David L. DeWitt, William G. Stetler-Stevenson, Larry M. Wahl (1994) “Interleukin 10 Suppression of Monocyte Prostaglandin H Synthase-2”Journal of Biological Chemistry269(33):21322-21329.
Rasanen, L. et al. (1988) “Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus”Clin. Exp. Immunol.71:470-474.
Ristimaki, Ari, Susan Garfinkel, Jorg Wessendorf, Thomas Maciag, Timothy Hla (1994) “Induction of Cyclooxygenase-2 by Interleukin- 1α”Journal of Biological Chemistry269(16):11769-11775.
Seldon, Paul M., Peter J. Barnes, Koremu Meja, Mark A. Giembycz (1995) “Suppression of Lipopolysaccharide-Induced Tumor Necrosis Factor-α Generation from Human Peripheral Blood Monocytes by Inhibitors of Phosphodiesterase 4:Interaction with Stimulants of Adenylyl Cyclase”Molecular Pharmacology48:747-757.
Serreze, David V. (1993) “Autoimmune diabetes results from genetic defects manifest by antigen presenting cells”J. FASEB7:1092-1096.
Spengler, R.N. (1989) “Modulation of Tumor Necrosis Factor-α Gene Expression Densensitization of Prostaglandin E2-Induced Suppression”Journal of Immunology142(12):4346-4350.
Strassmann, Gideon, Vina Patil-Koota, Fred Finkelman, Miranda Fong, Taku Kambayashi (1994) “Evidence for the Involvement of Interleukin 10 in the Differential Deactivation of Murine Peritoneal Macrophages by Prostaglandin E2”Journal of Experimental Medicine180:2365-2370.
Strieter, R.M. et al. (1990) “Tumor Necrosis Factor-Alpha Gene Expression in Human Whole Blood”Journal of Leukocyte Biology47:366-370.
Vane, J.R. et al. (1994) “Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation”Proc. Natl. Acad. Sci. USA91:2046-2050.
Via, Charles S., George C. Tsokos, Bonnie Bermas, Mario Clerici, Gene M. Shearer (1993) “T Cell-Antigen-Presenting Cell Interactions in Human Systemic Lupus Erythematosus”Journal of Immunology151(7):3914-3922.
Zhong, W.W., P.A. Burke, M.E. Drotar, S.R. Chavali, R.A. Forse (1995) “Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages”Immunology84:446-452.
Hellstrand, K., S. Hermodsson (1989) “Interleukin-2 can induce suppression of human natural killer cell cytotoxicity”Clin. Exp. Immunol.77:410-416.
Faist, E., W. Erthel, T. Cohnert, P. Huber, D. Inthorn, G. Heberer (1990) “Immunoprotective Effects of Cyclooxygenase Inhibition in Patients with Major Surgical Trauma”The Journal of Trauma30(1):8-17.
Wahl, Sharon M. (1992) “Transforming Growth Factor Beta (TGF-β) in Inflammation: A Cause and a Cure”Journal of Clinical Immunology12(2):61-74, see ref 103-105 see p 60.
Reder, Anthony T., Manjula Thapar, Anna Maria Sapugay, Mark A. Jensen (1994) “Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis”Journal of Neuroimmunology54:117-127.
Chulada, Patricia C., Robert Langenbach (1997) “Differential Inhibition of Murine Prostaglandin Synthase-1 and -2 by Nonsteroidal Anti-Inflammatory Drugs Using Exogenous and Endoogenous Sources of Arachidonic Acid”Journal of Pharmacology and Experimental Therapeut280(2):606-613.
Physician's Desk Reference, 49thEdition, 1995, pp. 1566-1571.
Secchi, A. et al. (1986) “Prednisone, Indomethacin, or Theophylline Administration and the Remission Phase in Recent Onset Type I Insulin-Dependent Diabetic Patients”Transplantation Proceedings, XVIII, 1540-1542.
Goodwin, James S., David R. Webb (1980) “Regulation of the Immune Response by Prostaglandins”Clinical Immunology and Immunopathology15:106-122.
Mountz, John Douglas, Tong Zhou, Xiao Su, Jianguo Wu, Jianhua Cheng (1996) “The Role of Programmed Cell Death as an Emerging New Concept for the Pathogenesis of Autoimmune Diseases”Clinical Immunology and Immunopathology80(3):S2-S14.
Gold, R., M. Schmied, U. Tontsch, H.P. Hartung, H. Wekerle, K.V. Toyka, H. Lassmann (1996) “Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death, A model for T-cell apoptosis in vivo”Brain119:651-659.
Ballif, Bryan A., Natalie V. Mincek, Justin T. Barratt, Michael L. Wilson, Daniel L. Simmons (1996) “Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein”Proc. Natl. Acad. sci. USA93:5544-5549.
Santoil, Daniels, Paul D. Phillips, Tammy L. Colt, Robert B. Zurier ((1990) “Suppression on Interleukin 2-dependent Human T Cell Growth in vitro by Prostaglandin E (PGE) and Their Precursor Fatty Acids”J. Clin. Invest.85:424-432.
Trauth, Bernhard C., Christiane Klas, Anke M. J. Peters, Siegfried Matzku, Peter Moller, Werner Falk, Klau-Michael Debatin, Peter H. Krammer (1989) “Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis” (1989)Science245:301-305.
Valerio, G., N. Gasparini, R. Badolato, S. Di Maio, A. Tenore (1994) “Impairment of T-cell growth-promoting lymphokines in human insulin-dependent diabetes mellitus”Acta Diabetol31:52-57.
Saliwanchik Lloyd & Saliwanchik
Saunders David
University of Florida Research Foundation Inc.
LandOfFree
Materials and methods for detection and treatment of immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Materials and methods for detection and treatment of immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for detection and treatment of immune... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3483247